Robert Naso

1.8k total citations
27 papers, 1.4k citations indexed

About

Robert Naso is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Robert Naso has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Immunology and 9 papers in Epidemiology. Recurrent topics in Robert Naso's work include Antimicrobial Resistance in Staphylococcus (9 papers), HIV Research and Treatment (6 papers) and Virus-based gene therapy research (6 papers). Robert Naso is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), HIV Research and Treatment (6 papers) and Virus-based gene therapy research (6 papers). Robert Naso collaborates with scholars based in United States, Germany and United Kingdom. Robert Naso's co-authors include Ali Fattom, Gary Horwith, Ralph B. Arlinghaus, Steve Fuller, L.J. Arcement, Larry R. Muenz, Rachel Schneerson, John B. Robbins, Henry R. Shinefield and David Law and has published in prestigious journals such as New England Journal of Medicine, Cell and Blood.

In The Last Decade

Robert Naso

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Naso United States 17 635 597 325 230 174 27 1.4k
Gunnar Haukenes Norway 22 502 0.8× 382 0.6× 468 1.4× 178 0.8× 121 0.7× 106 1.4k
Farida Nato France 26 495 0.8× 282 0.5× 216 0.7× 272 1.2× 116 0.7× 49 1.7k
Rob Striker United States 26 721 1.1× 599 1.0× 563 1.7× 219 1.0× 58 0.3× 66 2.3k
Raymond J. Jackson United States 22 486 0.8× 319 0.5× 332 1.0× 774 3.4× 181 1.0× 28 1.6k
Birgid Neumeister Germany 22 1.0k 1.6× 531 0.9× 251 0.8× 459 2.0× 299 1.7× 53 2.1k
Patricia McGraw United States 19 805 1.3× 303 0.5× 463 1.4× 239 1.0× 44 0.3× 25 1.6k
F J Silverblatt United States 21 505 0.8× 240 0.4× 344 1.1× 141 0.6× 167 1.0× 36 1.5k
G M Bahr Kuwait 22 584 0.9× 518 0.9× 437 1.3× 540 2.3× 75 0.4× 67 1.5k
Neelam Dhiman United States 26 576 0.9× 551 0.9× 987 3.0× 566 2.5× 81 0.5× 64 1.9k
Pia Hartmann Germany 26 325 0.5× 562 0.9× 651 2.0× 417 1.8× 50 0.3× 76 1.9k

Countries citing papers authored by Robert Naso

Since Specialization
Citations

This map shows the geographic impact of Robert Naso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Naso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Naso more than expected).

Fields of papers citing papers by Robert Naso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Naso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Naso. The network helps show where Robert Naso may publish in the future.

Co-authorship network of co-authors of Robert Naso

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Naso. A scholar is included among the top collaborators of Robert Naso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Naso. Robert Naso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fattom, Ali, Steve Fuller, Scott Winston, et al.. (2004). Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients. Vaccine. 23(5). 656–663. 75 indexed citations
3.
Robbins, John B., Rachel Schneerson, Gary Horwith, Robert Naso, & Ali Fattom. (2004). Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. American Heart Journal. 147(4). 593–598. 30 indexed citations
4.
5.
Shinefield, Henry R., Steven Black, Ali Fattom, et al.. (2002). Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis. New England Journal of Medicine. 346(7). 491–496. 351 indexed citations
6.
Sood, Ramesh, V. S. Bhadti, Ali Fattom, et al.. (2002). Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells. Antiviral Research. 53(2). 159–164. 10 indexed citations
7.
Zhang, Ning, Huanming Chen, Ramesh Sood, et al.. (2002). in vitro inhibition of the measles virus by novel ring-expanded (‘fat’) nucleoside analogues containing the imidazo[4,5-e]diazepine ring system. Bioorganic & Medicinal Chemistry Letters. 12(23). 3391–3394. 17 indexed citations
8.
Pentel, Paul R., David H. Malin, Yoko Hieda, et al.. (2000). A Nicotine Conjugate Vaccine Reduces Nicotine Distribution to Brain and Attenuates Its Behavioral and Cardiovascular Effects in Rats. Pharmacology Biochemistry and Behavior. 65(1). 191–198. 145 indexed citations
9.
10.
Fattom, Ali & Robert Naso. (1996). Staphylococcus aurcus Vaccination for Dialysis Patients-An Update. Advances in Renal Replacement Therapy. 3(4). 302–308. 3 indexed citations
11.
Naso, Robert & Ali Fattom. (1996). Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections. Advances in experimental medicine and biology. 397. 133–140. 4 indexed citations
12.
Fattom, Ali & Robert Naso. (1996). Staphylococcal Vaccines: A Realistic Dream. Annals of Medicine. 28(1). 43–46. 19 indexed citations
13.
Fattom, Ali, Xiuru Li, Abbas Hawwari, et al.. (1995). Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine. 13(14). 1288–1293. 43 indexed citations
14.
Schoenberg, Mark, et al.. (1984). Induction of Proteins in Human Lymphoblastoid Cells by Recombinant Alpha Interferon. Journal of Interferon Research. 4(1). 67–79. 5 indexed citations
15.
Naso, Robert, et al.. (1982). Antiretroviral Effect of Interferon: Proposed Mechanism. Journal of Interferon Research. 2(1). 75–96. 16 indexed citations
16.
Robey, W G, Marianne Oskarsson, George F. Vande Woude, et al.. (1977). Cells transformed by certain strains of moloney sarcoma virus contain murine p60. Cell. 10(1). 79–89. 38 indexed citations
17.
Naso, Robert & Ronald L. Brown. (1977). Synthesis and cleavage of rauscher leukemia virus precursor proteins in synchronized cell. Virology. 82(1). 247–251. 5 indexed citations
18.
Naso, Robert, et al.. (1975). The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 383(2). 195–206. 35 indexed citations
19.
Naso, Robert, et al.. (1973). Ribosomes from Rauscher leukemia virus-infected cells and their response to Rauscher viral RNA and polyuridylic acid. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 324(3). 346–364. 16 indexed citations
20.
Naso, Robert, et al.. (1972). C-type virus particles produced by normal mouse spleen-thymus cultures. Virology. 47(2). 521–524. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunnar Haukenes Breakdown of academic impact, for papers by Farida Nato Breakdown of academic impact, for papers by Rob Striker Breakdown of academic impact, for papers by Raymond J. Jackson Breakdown of academic impact, for papers by Birgid Neumeister Breakdown of academic impact, for papers by Patricia McGraw Breakdown of academic impact, for papers by F J Silverblatt Breakdown of academic impact, for papers by G M Bahr Breakdown of academic impact, for papers by Neelam Dhiman Breakdown of academic impact, for papers by Pia Hartmann
Rankless by CCL
2026